Generics - North America, Anti-Arthritics/Rheumatics

Filter

Popular Filters

Prasco to market the authorized generic of Lilly’s Evista in USA

01-04-2014

Privately-held US generics firm Prasco has signed a further deal with US pharma major Eli Lilly to market…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsMarkets & MarketingNorth AmericaPrasco LaboratoriesUSA

Teva gains approval for generic Evista in the USA

Teva gains approval for generic Evista in the USA

04-03-2014

Israel-based Teva Pharmaceutical Industries says it has received approval from the US Food and Drug Administration…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsNorth AmericaRegulationTeva Pharmaceutical IndustriesUSA

Actavis challenges Multaq and Colcrys patents

02-03-2014

Ireland-headquartered generic drugmaker Actavis revealed on Friday (February 28) that French pharma giant…

ActavisAnti-Arthritics/RheumaticsCardio-vascularColcrysGenericsLegalMultaqNorth AmericaPatents & Trade marksRegulationSanofiTakeda PharmaceuticalsUSA

Horizon Pharma in Duexis patent settlement

22-08-2013

Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

US FDA accepts Pennsaid 2% NDA for review

22-08-2013

The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

USPTO grants Pfizer reissue patent for Celebrex, extending term to Dec 2015

06-03-2013

Global pharma behemoth Pfizer (NYSE: PFE) said yesterday that the US Patent & Trademark Office has granted…

Anti-Arthritics/RheumaticsApotexCelebrexGenericsLupinMylan LaboratoriesNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Nuvo Research in patent settlement over Pennsaid

29-01-2013

Canada's Nuvo Research (TSX: NRI) says it has entered into a settlement agreement with Apotex Inc and…

Anti-Arthritics/RheumaticsApotexGenericsMallinckrodtNorth AmericaNuvo ResearchPatentsPennsaid

Mylan settles over Brovana; launches generic Boniva in UK and Italy

27-05-2012

US generic drugs major Mylan (Nasdaq: MYL) has entered into an agreement with Sunovion Pharmaceuticals,…

Anti-Arthritics/RheumaticsBonivaBrovanaDainippon Sumitomo PharmaEuropeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryRocheSunovion

FDA approves first generics of Roche osteo drug Boniva

20-03-2012

The US Food and Drug Administration yesterday approved the first generic versions of Boniva (ibandronate)…

Anti-Arthritics/RheumaticsApotexBonivaGenericsMylan LaboratoriesNorth AmericaOrchid HealthcareRegulationRoche

Biosimilars of TNF-alpha inhibitors and pegylated IFN-alpha agents set to save health care systems $5.3 billion in 2020

04-10-2011

Biosimilar versions of tumor necrosis factor (TNF)-alpha inhibitors and pegylated interferon (IFN)-alpha…

Anti-Arthritics/RheumaticsBiotechnologyEuropeGastro-intestinalsGenericsMarkets & MarketingNorth America

Amgen gains EU approval for Xgeva; Resolves G-CSF patent dispute with Teva

18-07-2011

The European Commission has granted marketing authorization for US biotech giant Amgen’s (Nasdaq:…

AmgenAnti-Arthritics/RheumaticsEuropeGenericsNeupogenNeutrovalNorth AmericaOncologyPatentsPharmaceuticalRegulationTeva Pharmaceutical IndustriesXgeva

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top